Huang Xiaochao, Huang Rizhen, Wang Zhimei, Li Lingxue, Gou Shaohua, Liao Zhixin, Wang Hengshan
Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China.
Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China.
Eur J Med Chem. 2018 Feb 25;146:435-450. doi: 10.1016/j.ejmech.2018.01.075. Epub 2018 Feb 4.
Six novel of Pt(IV) complexes comprising chalcone analogues were synthesized and evaluated for anti-proliferative activity using MTT assay. In vitro evaluation revealed that all Pt(IV) complexes showed better and more potent activity against three human cancer cells including CDDP resistant cells than that of their corresponding mother Pt(II) species. Among them, two representative complexes, 14 and 17, exhibited better cell selectivity between cancer cells and normal cells than CDDP. Molecular docking study indicated that complexes 14 and 17 could bind to the colchicine site of tubulin. Moreover, complexes 14 and 17 also remarkably displayed inhibition of cell migration against HUVEC cells in vitro. Molecular mechanism studies suggested that 14 and 17 induced production of reactive oxygen species (ROS), cell cycle arrest at the G2/M phase, and mitochondria-mediated apoptosis by regulating the expression of Bcl-2 family members.
合成了六种含查尔酮类似物的新型铂(IV)配合物,并使用MTT法评估其抗增殖活性。体外评估表明,所有铂(IV)配合物对包括顺铂耐药细胞在内的三种人类癌细胞均表现出比其相应母体铂(II)物种更好、更有效的活性。其中,两种代表性配合物14和17在癌细胞和正常细胞之间表现出比顺铂更好的细胞选择性。分子对接研究表明,配合物14和17可与微管蛋白的秋水仙碱位点结合。此外,配合物14和17在体外也显著抑制人脐静脉内皮细胞(HUVEC)的细胞迁移。分子机制研究表明,14和17通过调节Bcl-2家族成员的表达诱导活性氧(ROS)产生、细胞周期阻滞于G2/M期以及线粒体介导的细胞凋亡。